Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...
DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...
Bearish flow noted in DexCom (DXCM) with 11,940 puts trading, or 4x expected. Most active are 12/27 weekly 59 puts and 12/27 weekly 77 puts, ...
DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.41 which represents a slight increase of $0.69 or 0.89% from the prior close of $77.72. The stock opened at $78.09 and touched a low ...
The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...
In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...
“行业观察者”是我们针对人工智能、XR、元宇宙和Web3等前沿科技而设立的专栏,主要分享这些领域中的新兴企业或者创业者们的故事。智能戒指制造商Oura获得了美国连续血糖监测(CGM)巨头Dexcom领投的7500万美元融资,并建立战略合作伙伴关系,现 ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...
高估值背后,是Oura出色的商业化表现。根据前段时间公布的数据,Oura的智能戒指已经销售了250多万枚,今年的销量额将翻一番,达到5亿美金。而且,根据CEO Tom Hale的说法,Oura的利润率远高于传统硬件制造商,甚至接近软件公司。
Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...
Canaccord analyst William Plovanic raised the firm’s price target on DexCom (DXCM) to $99 from $89 and keeps a Buy rating on the shares.